MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Income Tax Expense · Q1 FY2026 · quarter ended Jul 2026
Income tax expense of $4M in Q1 FY2026
Q1 FY2026 income tax expense was $4M. Trailing-twelve-month income tax expense was $128M. Over 3 fiscal years it compounded at +100.0% a year.
Context
- Income tax expense amounted to 4.1% of revenue in FY2025, up 2.4 pp from a year earlier.
- Income tax expense increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly income tax expense holds near $4M or moves back toward the trailing-twelve-month quarterly average of $32M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 128M USD
- Year-over-year change
- +166.7%
- 3-year CAGR
- +100.0%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | 128M | +166.7% |
| FY2024 | 2025-04-30 | 48M | +26.3% |
| FY2023 | 2024-04-30 | 38M | +137.5% |
| FY2022 | 2023-04-30 | 16M | — |
Income Tax Expense vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 income tax expense of $128M is the 3rd highest of the 7 companies compared; the peer median is $59.65M.
- Income tax expense amounts to 4.0% of revenue for MMED, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $1.33B | +37.1% | -6.3% | 3.6% | |
| LTM Jun 2026 | $280.3M | +31.8% | +71.9% | 5.6% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $128M | — | +100.0% | 4.0% |
| LTM Jun 2026 | $119.3M | +244.8% | +160.9% | 3.9% | |
| LTM Mar 2026 | $1K | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | -$3.51M | -137.2% | +36.6% | 0.3% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $59.65M | +34.5% | +54.3% | 1.9% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Revenue | 2.25B | 2.47B | 2.72B | 3.1B |
| Cost of Revenue | 937M | 1.03B | 1.19B | 1.42B |
| Gross Profit | 1.31B | 1.44B | 1.53B | 1.68B |
| Gross Margin | 58.3% | 58.2% | 56.2% | 54.2% |
| Research & Development | 429M | 437M | 438M | 448M |
| Selling, General & Admin | 960M | 1.06B | 1.13B | 1.18B |
| Operating Expenses | 1.38B | 1.51B | 1.73B | 1.63B |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| EBITDA | 39M | 59M | 107M | 205M |
| EBITDA Margin | 1.7% | 2.4% | 3.9% | 6.6% |
| Operating Income | (69M) | (69M) | (202M) | 49M |
| Operating Margin | -3.1% | -2.8% | -7.4% | 1.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (7M) | (1M) | (1M) | (236M) |
| Income Before Tax | (76M) | (70M) | (203M) | (187M) |
| Pre-Tax Margin | -3.4% | -2.8% | -7.5% | -6.0% |
| Income Tax Expense | 16M | 38M | 48M | 128M |
| Net Income | (96M) | (112M) | (250M) | (331M) |
| Net Margin | -4.3% | -4.5% | -9.2% | -10.7% |
| EPS (Basic) | (0.34) | (0.40) | (0.89) | (1.29) |
| EPS (Diluted) | (0.34) | (0.40) | (0.89) | (1.29) |
| Weighted Avg Shares | 280.81M | 280.81M | 280.81M | 256.6M |
| Weighted Avg Shares (Diluted) | 280.81M | 280.81M | 280.81M | 256.6M |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.